United States · FDA National Drug Code directory
Olanzapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72303-0843_4d1b8476-a9ab-067a-e063-6294a90a57c0
- Product NDC
- 72303-0843
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Olanzapine
- Labeler
- HEC Pharm USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260317
- Source listing expiry
- 20271231
Source-listed ingredients
- OLANZAPINE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (72303-0843-1) · 72303-0843-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →